FDA to consider MDMA as treatment for PTSD

An FDA panel of independent advisers is set to consider the first potential new post-traumatic stress disorder treatment in 25 years — MDMA — NBC News reported May 7.

Read the full post on Becker's Hospital Review | Healthcare News & Analysis